Recently, 2-(nicotinamide)-1,3,4-thiadiazole (TGN-020) was identified as a novel aquaporin 4 (AQP4) inhibitor and administration of TGF-020 reduced ischemic cerebral edema in mice [151]. Here, AQP4 is linked to brain edema.